UNSPSC 85252803: Diagnosis of mixed cellularity classical hodgkin lymphoma

This classification denotes the group of activities that yields a diagnosis of Mixed cellularity classical Hodgkin lymphoma. Mixed cellularity classical Hodgkin lymphoma is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code C81. 2

UNSPSC 85252803 Diagnosis of mixed cellularity classical hodgkin lymphoma is a Commodity code that shows a material mismatch between its nominal scope and recent state and local procurement activity. The code nominally describes a specific pathological diagnostic procedure, yet the three most recent opportunities tagged under it involve diagnostic imaging systems procurement, special education contracted services, and temporary health professional staffing—none of which align with lymphoma diagnosis. San Mateo Medical Center is procuring an enterprise-grade diagnostic imaging PACS system with EPIC EHR integration to support radiology, cardiology, and dental imaging; Birdville Independent School District is soliciting on-site special education professionals including audiologists, diagnosticians, and therapists; and Santa Clara Health System is establishing a qualified vendor pool for temporary ancillary clinical staffing across audiology, radiology, cardiology, and therapy services. State and local procurement offices appear to be misapplying this code to health professional services and imaging infrastructure that fall outside its intended scope.

The geographic activity is concentrated in California and Texas. San Mateo Medical Center (California county health system) posted an RFP for diagnostic imaging PACS with an October 21, 2026 response deadline; Santa Clara Health System (California) posted an RFQ for temporary health professional staffing with an October 7, 2026 deadline; and Birdville Independent School District (Texas) posted an ITB for special education services with an October 21, 2026 deadline. No current opportunities under this code represent actual hodgkin lymphoma diagnostic services. Business development professionals should flag the code-opportunity mismatch with procurement offices before pursuing; the code appears to be misclassified in at least these three recent requisitions.